Binoid vs. Delta Extrax: Two Δ8 Storefronts, Judged on the Maps They Publish
Both ship nationally, both post a list of states they refuse to ship to, and the two lists disagree by fourteen states. A close read of what each company puts in writing about its paperwork and its map — and of the state neither one names.
Two national storefronts. One country. Two materially different maps of it.
Updated 7 November 2026: details are re-sourced to primary documents, and lines with no primary document are cut.
Updated 6 November 2026: the score is removed; this is now an assessment of published documents.
Binoid and Delta Extrax both sell Δ8 and adjacent cannabinoids by mail, and both do what this category’s better operators do: publish a list of states they will not ship to. Laid over each other, the lists agree on nine states and disagree on fourteen. Not a scandal — just an honest picture of how much of this geography is a judgment call.
So this compares no cartridge contents. We have no laboratory. It compares the two documents a buyer can read before spending money: the lab-results index and the restricted-state list.
The two dossiers
The lab-sheet test
Every review here starts in one place: how much work is it to reach the certificate of analysis — the batch lab report — for the thing in your cart?
Both pass, in different registers. Binoid’s lab-results page is browsable: reports sit in labelled groups you can scroll, no support email required.
Extrax’s lab-test page organises the other way — by category, then product line, then variant against a batch code. That forces the check a COA exists for: batch on the report against batch on the package. It is also more demanding: you need your flavour and code before the page helps.
Then the shared weakness. Neither page we read names the laboratory behind its reports, or that lab’s accreditation — the outside audit of a lab’s methods. Without it a COA says what somebody measured and little about the somebody. That gap matters most for converted cannabinoids, where the rows worth reading are residual solvents and conversion byproducts, and an unnamed lab’s methods do the work.
The maps, laid over each other
Nine states sit on both lists: Alaska, California, Colorado, Idaho, Oregon, Rhode Island, Utah, Vermont and Washington. Call that the consensus. Outside it the divergence is wide — eight states Extrax refuses, Arizona and New York among them, appear on neither Binoid list, and six Binoid withholds from, Kansas and West Virginia included, are absent from Extrax’s.
Credit to both on structure. Binoid splits restrictions by product class, treating Δ-series and THC-A separately, which is closer to how state rules actually differ. Extrax’s flat list is blunter but readable at a glance, and it sits on the shipping policy rather than at the foot of a lab page.
Neither is a legal opinion. A shipping list is a company’s risk posture — counsel, carriers, payment processing and appetite, in proportions nobody publishes. Two lists this different are the proof.
The state neither map names
Texas appears on no list on either site as of late August.
Texas is the case in point. Per the DSHS consumable hemp page, read on 7 November 2026, delta-8 THC is a controlled substance in Texas and only naturally occurring trace amounts in a hemp plant are exempt, and the schedule affecting delta-8 took effect on 31 July 2026. We will not guess how that ends.
The lesson does not depend on the outcome. A state’s absence from a seller’s list is not a finding that anything is permitted there; it means the seller has not listed it. Your own bucket on the state patchwork governs your cart. A checkout page does not, and neither do we.
The marketplace wrinkle
Both increasingly sell other people’s brands — Binoid’s index carries reports for stocked third-party lines, the 3Chi catalogue we assessed separately among them, and Extrax runs a marketplace beside its house products. For shoppers that is range. For paperwork it is a longer chain: a retailer publishing a report it did not commission, for a batch it did not make, from a lab it does not name.
One boundary belongs on this map as much as the state lines: nothing either company sells has been evaluated by the FDA, we describe no effects and recommend no quantities, and the shelf is adults 21 and over, where your state allows it.
The ledger
Our assessment
This is an assessment of published documents, not of anything either company sells: Binoid edges it on how easily a report is reached; Extrax on how tightly each report is tied to a batch. Neither names a lab, and neither map has caught up with Texas.
Who is this for? Binoid suits the reader who browses lab work first and shops second; Extrax the reader who knows the product and wants the report for that run. Anyone reading a shipping list as a green light should skip both — lists that disagree on fourteen states answer no legal question, and yours starts with your own state.
Documents read
Read on 6 November 2026:
- Delta Extrax shipping policy: Lists states it does not ship to: Alaska, Arizona, California, Colorado, Delaware, Idaho, Iowa, Mississippi, Montana, Nevada, New York, North Dakota, Oregon, Rhode Island, Utah, Vermont, Washington.
- Binoid lab results page: Lab results listed by product with labels such as 2022 Δ8 strains and 2024 distillate COAs (HHC, HHC-P, THC-JD). I did not confirm the third-party brand reports in the part I read.
- Binoid shipping policy: States Binoid does not ship any Delta products to CA, OR, AK, WV, WA or CO, and THC-A is unavailable for shipment to AR, HI, ID, KS, LA, OK, OR, RI, UT, VT, WA, WV; the n.
- Texas DSHS Consumable Hemp Program: Read 7 November 2026. Delta-8 THC is a controlled substance; only naturally occurring trace amounts in a hemp plant are exempt; the schedule affecting delta-8 THC became effective on 31 July 2026.